Literature DB >> 18602166

CCL genes in multiple sclerosis and systemic lupus erythematosus.

Tamara Vyshkina1, Andrew Sylvester, Saud Sadiq, Eduardo Bonilla, Andras Perl, Bernadette Kalman.   

Abstract

This follow up study aims to refine the roles of previously suggested candidate genes (CC chemokine ligands or CCLs) in multiple sclerosis (MS), and to test these markers in another autoimmune disorder, systemic lupus erythematosus (SLE). After stringent correction for multiple testing, we reject the importance of previously suggested borderline associations with CCLs in MS. A new finding is the differential distribution of CCL8 marker alleles and a haplotype in extreme severity subgroups of MS. In SLE, this study reveals strong associations with a marker and a haplotype encompassing the CCL14 gene, which suggests that a lupus relevant variant may lie within or in the proximity of this haplotype.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18602166      PMCID: PMC5301077          DOI: 10.1016/j.jneuroim.2008.05.016

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  43 in total

1.  Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits.

Authors:  S Purcell; S S Cherny; P C Sham
Journal:  Bioinformatics       Date:  2003-01       Impact factor: 6.937

2.  HCC-2, a human chemokine: gene structure, expression pattern, and biological activity.

Authors:  A Pardigol; U Forssmann; H D Zucht; P Loetscher; P Schulz-Knappe; M Baggiolini; W G Forssmann; H J Mägert
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

3.  Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination.

Authors:  C Lucchinetti; W Brück; J Parisi; B Scheithauer; M Rodriguez; H Lassmann
Journal:  Ann Neurol       Date:  2000-06       Impact factor: 10.422

4.  Testing for linkage disequilibrium in genotypic data using the Expectation-Maximization algorithm.

Authors:  M Slatkin; L Excoffier
Journal:  Heredity (Edinb)       Date:  1996-04       Impact factor: 3.821

5.  Sequence polymorphisms in the chemokines Scya1 (TCA-3), Scya2 (monocyte chemoattractant protein (MCP)-1), and Scya12 (MCP-5) are candidates for eae7, a locus controlling susceptibility to monophasic remitting/nonrelapsing experimental allergic encephalomyelitis.

Authors:  C Teuscher; R J Butterfield; R Z Ma; J F Zachary; R W Doerge; E P Blankenhorn
Journal:  J Immunol       Date:  1999-08-15       Impact factor: 5.422

6.  Chromosome 17p12-q11 harbors susceptibility loci for systemic lupus erythematosus.

Authors:  Cecilia M Johansson; Renata Zunec; Mercedes A García; Hugo R Scherbarth; Guillermo A Tate; Sergio Paira; Sandra M Navarro; Carlos E Perandones; Susana Gamron; Alejandro Alvarellos; Cesar E Graf; Jorge Manni; Guillermo A Berbotto; Simon A Palatnik; Luis J Catoggio; Cristina G Battagliotti; Gian Domenico Sebastiani; Sergio Migliaresi; Mauro Galeazzi; Bernardo A Pons-Estel; Marta E Alarcón-Riquelme
Journal:  Hum Genet       Date:  2004-07-01       Impact factor: 4.132

Review 7.  Mapping the systematic lupus erythematosus susceptibility genes.

Authors:  Swapan K Nath; Jennifer A Kelly; John B Harley; R Hal Scofield
Journal:  Methods Mol Med       Date:  2004

8.  Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosis.

Authors:  Frida Lundmark; Kristina Duvefelt; Ellen Iacobaeus; Ingrid Kockum; Erik Wallström; Mohsen Khademi; Annette Oturai; Lars P Ryder; Janna Saarela; Hanne F Harbo; Elisabeth G Celius; Hugh Salter; Tomas Olsson; Jan Hillert
Journal:  Nat Genet       Date:  2007-07-29       Impact factor: 38.330

9.  Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.

Authors:  W I McDonald; A Compston; G Edan; D Goodkin; H P Hartung; F D Lublin; H F McFarland; D W Paty; C H Polman; S C Reingold; M Sandberg-Wollheim; W Sibley; A Thompson; S van den Noort; B Y Weinshenker; J S Wolinsky
Journal:  Ann Neurol       Date:  2001-07       Impact factor: 10.422

10.  HLA-A confers an HLA-DRB1 independent influence on the risk of multiple sclerosis.

Authors:  Boel Brynedal; Kristina Duvefelt; Gudrun Jonasdottir; Izaura M Roos; Eva Akesson; Juni Palmgren; Jan Hillert
Journal:  PLoS One       Date:  2007-07-25       Impact factor: 3.240

View more
  9 in total

1.  Towards a Better Crystal Ball: Urinary C-C Motif Chemokine Ligand 14 (CCL14) and Persistent Severe AKI.

Authors:  Justin M Belcher
Journal:  Kidney360       Date:  2022-07-28

2.  Association of common mitochondrial DNA variants with multiple sclerosis and systemic lupus erythematosus.

Authors:  Tamara Vyshkina; Andrew Sylvester; Saud Sadiq; Eduardo Bonilla; Jeff A Canter; Andras Perl; Bernadette Kalman
Journal:  Clin Immunol       Date:  2008-08-16       Impact factor: 3.969

3.  Gene expression in thiazide diuretic or statin users in relation to incident type 2 diabetes.

Authors:  Astrid Suchy-Dicey; Susan R Heckbert; Nicholas L Smith; Barbara McKnight; Jerome I Rotter; Yd Ida Chen; Bruce M Psaty; Daniel A Enquobahrie
Journal:  Int J Mol Epidemiol Genet       Date:  2014-02-17

4.  CXCL13 polymorphism is associated with essential hypertension in Tatars from Russia.

Authors:  Yanina R Timasheva; Timur R Nasibullin; Ilsiyar A Tuktarova; Vera V Erdman; Olga E Mustafina
Journal:  Mol Biol Rep       Date:  2018-07-17       Impact factor: 2.316

5.  Single-nucleotide polymorphisms in genes encoding for CC chemokines were not associated with the risk of non-Hodgkin lymphoma.

Authors:  Qiong Chen; Tongzhang Zheng; Qing Lan; Catherine Lerro; Nan Zhao; Qin Qin; Xiaobin Hu; Huang Huang; Jiaxin Liang; Theodore Holford; Brian Leaderer; Peter Boyle; Stephen J Chanock; Nathaniel Rothman; Yawei Zhang
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-05-02       Impact factor: 4.254

6.  The Association of Chemokine Gene Polymorphisms with VKH and Behcet's Disease in a Chinese Han Population.

Authors:  Yang Huang; Hongsong Yu; Qingfeng Cao; Jing Deng; Xinyue Huang; Aize Kijlstra; Peizeng Yang
Journal:  Biomed Res Int       Date:  2017-05-14       Impact factor: 3.411

7.  Identification and validation of biomarkers of persistent acute kidney injury: the RUBY study.

Authors:  Eric Hoste; Azra Bihorac; Ali Al-Khafaji; Luis M Ortega; Marlies Ostermann; Michael Haase; Kai Zacharowski; Richard Wunderink; Michael Heung; Matthew Lissauer; Wesley H Self; Jay L Koyner; Patrick M Honore; John R Prowle; Michael Joannidis; Lui G Forni; J Patrick Kampf; Paul McPherson; John A Kellum; Lakhmir S Chawla
Journal:  Intensive Care Med       Date:  2020-02-06       Impact factor: 17.440

8.  CCL14 serves as a novel prognostic factor and tumor suppressor of HCC by modulating cell cycle and promoting apoptosis.

Authors:  Mengxuan Zhu; Weiyue Xu; Chuanyuan Wei; Jing Huang; Jietian Xu; Yuye Zhang; Yan Zhao; Jie Chen; Shuangshuang Dong; Binbin Liu; Chunmin Liang
Journal:  Cell Death Dis       Date:  2019-10-22       Impact factor: 8.469

Review 9.  The kidney, COVID-19, and the chemokine network: an intriguing trio.

Authors:  Gianluigi Taverna; Simona Di Francesco; Elena Monica Borroni; Daniel Yiu; Elena Toniato; Samantha Milanesi; Maurizio Chiriva-Internati; Robert S Bresalier; Matteo Zanoni; Paolo Vota; Davide Maffei; Matteo Justich; Fabio Grizzi
Journal:  Int Urol Nephrol       Date:  2020-07-27       Impact factor: 2.370

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.